46.46.Z - Wholesale of pharmaceutical goods
46.38.Z - Wholesale of other food, including fish, crustaceans and molluscs
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
55.10.Z - Hotels and similar accommodation
55.20.Z - Holiday and other short-stay accommodation
64.19.Z - Other monetary intermediation
68.10.Z - Buying and selling of own real estate
68.20.Z - Rental and operating of own or leased real estate
72.19.Z - Other research and experimental development on natural sciences and engineering
86.90.E - Other human health activities notelsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 5 | 4,6 | 1,1 | -76,8 |
Gross profit (loss) | 5,1 | 4,7 | 1,1 | -76,9 |
EBITDA | 5,1 | 4,8 | 1 | -79,2 |
Short time liabilities | 3,2 | 0,4 | 0,3 | -25,3 |
Other operating costs | 0 | 0 | 0,1 | 218,2 |
Equity capital | 4,6 | 7,4 | 7,8 | 5,8 |
Operating profit (EBIT) | 5,1 | 4,7 | 1 | -79 |
Assets | 7,8 | 7,8 | 8,2 | 4,2 |
Net profit (loss) | 4,6 | 3,8 | 0,8 | -78,1 |
Cash | 1 | 2 | 2 | -0,9 |
Liabilities and provisions for liabilities | 3,2 | 0,4 | 0,3 | -25,3 |
Net income from sale | 8,7 | 11,6 | 5 | -56,9 |
Working assets | 7,8 | 4,3 | 4,4 | 1,8 |
Other income costs | 0,1 | 0,1 | 0 | -62,6 |
Depreciation | 0 | 0,1 | 0 | -86,2 |
% | % | % | p.p. | |
Profitability of capital | 99,5 | 51,1 | 10,6 | -40,5 |
Equity capital to total assets | 59,3 | 94,8 | 96,3 | 1,5 |
Gross profit margin | 58 | 40,5 | 21,7 | -18,8 |
EBITDA Margin | 58 | 41,3 | 20 | -21,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 133 | 13 | 22 | 9 |
Current financial liquidity indicator | 2.4602997303009033 | 10.745870590209961 | 14.641278266906738 | 3,9 |
Net dept to EBITDA | -0.20355863869190216 | -0.4205387830734253 | -2.005847930908203 | -1,6 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane